SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035433
Filing Date
2022-11-09
Accepted
2022-11-09 16:10:10
Documents
2
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2280
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4602
  Complete submission text file 0000899243-22-035433.txt   8242
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address
Arroyo Santiago (Reporting) CIK: 0001706857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 221372651